Blogs

Stay current with product and data science updates, industry and technology trends, and culture updates from the CancerLinQ team.

The Future of CancerLinQ - CEO Perspective

By Sean Khozin, MD, MPH
A patient-centered and equitable approach to transforming cancer care and research
Read More >

Transforming the Future of Cancer Care

ASCO Connection
In 2020, the CancerLinQ database surpassed over two million records from patients with cancer—an achievement that creates new opportunities for us to…
Read More >

Updated March 3, 2021 - Demographics of Patients with Cancer and COVID-19 Disease

CancerLinQ Data
Forty-four of the CancerLinQ practices providing regular data updates also provided testing information for and/or diagnostic reports of COVID-19…
Read More >

Impact of COVID-19 Disease on Oncology Practice: Targeted Therapies Used in Lung Cancer

COVID-19 Surveillance Report
Trends in prescription and/or administration of targeted therapies used in lung cancer by month since January 2019
Read More >

Impact of COVID-19 Disease on Oncology Practice: Aromatase inhibitors and tamoxifen

CancerLinQ Data
Trends in prescription and/or administration of aromatase inhibitors and tamoxifen by month since January 2019
Read More >

Impact of COVID-19 Disease on Oncology Practice: Chemotherapy Drug for Breast, Colon and Lung Cancer

COVID-19 Surveillance Report
This is the second in a series of reports on the impacts of COVID-19 disease on the practice of oncology as observed through de-identified CancerLinQ…
Read More >

Update on demographic data on COVID-19 patients in CancerLinQ

CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients
Read More >

View Recent COVID-19 Demographics

CancerLinQ Data
CancerLinQ is monitoring COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients.
Read More >

Observations on the Impact of COVID Disease on Oncology Practice from CancerLinQ: Telemedicine Encounters and Immune Checkpoint Inhibitors

COVID-19 Surveillance Report
Every day, the news has new reports of changes in the delivery of health care. At CancerLinQ, a learning health system developed by the American…
Read More >